Get started
Markets US Stocks Health Technology Pharmaceuticals: Major

Alzamend Neuro, Inc ALZN

ALZN NASDAQ
ALZN
Alzamend Neuro, Inc NASDAQ
See more on advanced chartSee more on advanced chart
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
News Ideas Financials Technicals

ALZN Chart

Ideas

Long | ALZN
ALZN
, 1DLong
ALZN: Long | ALZN

NASDAQ:ALZN Possible Scenario: LONG Evidence: Price Action, Call options, Strike 5$, 09/17/2021 20% Call options, Strike 2.5$, 10/15/2021 80% *This is my idea and could be wrong 100%.

$ALZN is gonna fall today
ALZN
, 15Short
ALZN: $ALZN is gonna fall today

Pupm&Dump trading strategy idea. $ALZN is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $9,63; stop-loss — $11,19; take-profit — $6,52. Do not view this idea as a recommendation for trading or investing. It is...

ALZN - Stock/Option Play
ALZN
, 120Long
ALZN: ALZN - Stock/Option Play

Alzheimer’s stock… Been taking a beating. Good point to enter with a quick stop and potential wedge breakout in the next week. Above the red resistance trend line and you’ll see one or more of the white targets above. Good luck if you play. In the cloud is chop but if it gets above those red clouds see ya

Technicals

Analyst rating

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Alzamend Neuro, Inc. is a preclinical stage biopharmaceutical company, which engages in the manufacture of pharmaceutical products. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders. The company was founded on February 26, 2016 by Milton C. Ault, III and is headquartered in Tampa, FL.

Breaking news

More news